College Station, Texas — According to state and local economic development sources Matica Biotechnology plans to invest $6,000,000.00 to build out 18,233 square feet of new space in College Station. The company plans to occupy the new space at 2501 Earl Rudder Freeway South in College Station, on or about April 1, 2022. According to the company website Matica Biotechnology, Inc. is a contract development and manufacturing organization (CDMO) specializing in the production of virus-based cell & gene therapeutics, oncolytic vectors and vaccines for our clients. Supported by our parent company, CHA Biotech, our new GMP facility in College Station, TX provides comprehensive support for your virus products including: GMP Production in Suspension and Microcarrier Platforms. QC Release and Stability Testing. Process Development and Scale-up. Assay Development and Phase-appropriate Validation. Cell and Virus Banking. Our LENTIVIRUS and AAV manufacturing platforms have been designed to streamline the CMC development cycle by optimizing biological components, processes and documentation to maximize titers, minimize impurities, and mitigate technical and regulatory risks. Our experts work hand-in-hand with your team guiding your project from technology transfer through to production and release of the final product. Throughout the lifetime of your program, a dedicated Project Manager is assigned to manage each activity step by step.

To learn more about Matica Biotechnology, visit http://www.maticabio.com/

Company Contact:
Yun Song, Chief Executive Officer
https://www.linkedin.com/in/yun-jeong-song-30353b25/
979-321-7500

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved